Revenue
2020
2021
2023
2024
2025
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $0 | $0 | $0 | — | $83,454 | $4,166 | — | — | — | — | — |
| Research & development | — | — | — | $1.6M | $842,500 | — | $447,418 | $2.1M | $4.7M | — | — |
| Operating expenses | $90,670 | $145,846 | $245,331 | $1.9M | $1.1M | $432,041 | $1.9M | $3.5M | $4.8M | $77,452 | $36,101 |
| Operating income | −$90,670 | −$145,846 | −$245,331 | −$1.9M | −$1.0M | −$427,875 | −$1.9M | −$3.5M | −$4.8M | −$77,452 | −$36,101 |
| Net income | −$596,140 | −$651,739 | −$760,690 | −$2.4M | −$1.5M | −$897,381 | −$2.4M | −$4.7M | −$5.1M | −$77,452 | −$36,101 |
| Basic EPSper diluted share | -$0.01 | -$0.01 | -$0.01 | -$0.02 | -$0.01 | -$0.01 | -$0.02 | -$0.17 | -$0.62 | -$0.01 | $0.00 |
| Diluted EPSper diluted share | -$0.01 | -$0.01 | -$0.01 | -$0.02 | -$0.01 | -$0.01 | -$0.02 | -$0.17 | -$0.62 | — | — |